Clopidogrel: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 5: | Line 5: | ||
'''''For patient information about Clopidogrel, click [[Clopidogrel (patient information)|here]].''''' | '''''For patient information about Clopidogrel, click [[Clopidogrel (patient information)|here]].''''' | ||
{{SB}} | {{SB}} PLAVIX | ||
==Overview== | ==Overview== | ||
| Line 13: | Line 13: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
==== | ====PLAVIX (clopidogrel bisulfate) tablet, film coated==== | ||
''' [[Clopidogrel indications and usage|Indications and Usage]]''' | ''' [[Clopidogrel indications and usage|Indications and Usage]]''' | ||
Revision as of 16:18, 6 March 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]
For patient information about Clopidogrel, click here.
Synonyms / Brand Names: PLAVIX
Overview
Category
FDA Package Insert
PLAVIX (clopidogrel bisulfate) tablet, film coated
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages